Sichuan Huiyu Pharmaceutical Co Ltd (688553) — Capital Reinvestment Ratio
Sichuan Huiyu Pharmaceutical Co Ltd (688553) has a Capital Reinvestment Ratio of 0.52x as of September 2025, meaning it reinvests 1% of its operating cash flow (CN¥58.54 Million) in capital expenditures (CN¥30.63 Million). See 688553 equity financing ratio to measure how much of total assets are equity-financed.
Capital Reinvestment Ratio
Operating Cash Flow
Capital Expenditures
Data as of
Sichuan Huiyu Pharmaceutical Co Ltd Capital Reinvestment Ratio (2018–2024)
This chart tracks Sichuan Huiyu Pharmaceutical Co Ltd's Capital Reinvestment Ratio across 7 annual periods. Check 688553 total capital reinvestment ratio to assess the company's total reinvestment commitment from operating cash flow.
Annual Capital Reinvestment Ratio for Sichuan Huiyu Pharmaceutical Co Ltd (2018–2024)
Year-by-year Capital Reinvestment Ratio for Sichuan Huiyu Pharmaceutical Co Ltd from 2018 to 2024. For live market cap and broader valuation context, see 688553 stock market capitalisation.
| Year | Reinvestment Ratio | Operating CF (CNY) | Capital Expenditures | YoY Change |
|---|---|---|---|---|
| 2024 | 0.53x | CN¥242.96 Million | CN¥128.18 Million | ▼ -88.1% |
| 2023 | 4.43x | CN¥66.93 Million | CN¥296.72 Million | ▲ +86.4% |
| 2022 | 2.38x | CN¥194.06 Million | CN¥461.61 Million | ▲ +145.0% |
| 2021 | 0.97x | CN¥446.36 Million | CN¥433.45 Million | ▲ +138.1% |
| 2020 | 0.41x | CN¥387.95 Million | CN¥158.24 Million | ▲ +21.0% |
| 2019 | 0.34x | CN¥326.22 Million | CN¥110.00 Million | ▲ +88.9% |
| 2018 | 0.18x | CN¥129.06 Million | CN¥23.04 Million | — |